Contact this trialFirst, we need to learn more about you.
Anti-VEGF
Aflibercept for Age-Related Macular Degeneration and Diabetic Macular Edema
Recruiting2 awardsPhase 3
Arcadia, California
This trial is testing a new drug called aflibercept 8 mg on people with nAMD and DME who have already used other medications. The goal is to see how safe and effective the drug
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.